회사 개요
Forian Inc. operates within the healthcare sector, specifically focusing on the health information services industry, where it delivers data management capabilities and analytics solutions to optimize operational, clinical, and financial performance for clients in life science, healthcare, and financial services. The company develops commercial and real-world evidence tools that enable customers to measure and enhance their performance across critical business functions. As of the latest reporting period, Forian Inc. maintains a market capitalization of $66.86M and generates annual revenue of $30.26M, supporting an employee base of 50 individuals. These financial figures indicate that Forian Inc. functions as a small-cap enterprise with a relatively modest revenue footprint compared to large-scale healthcare technology providers, suggesting a niche positioning within the broader market. The current market capitalization reflects investor sentiment regarding the company's growth potential in specialized data management niches, while the revenue level highlights its early-stage or high-growth phase typical of firms with limited headcount in the information services space.
재무 건전성
Forian Inc. reported revenue of $30.26M over the trailing twelve months, yet posted a net income of -$2,874,042 and an EBITDA of -$3,550,385, revealing a significant structural gap between top-line generation and bottom-line profitability. The substantial difference between revenue and net income indicates that the company's cost structure includes heavy operating expenses that currently outweigh its earnings before interest, taxes, depreciation, and amortization. Despite the negative net income and EBITDA, the company boasts a free cash flow of $3.90M, which provides essential financial flexibility to fund operations, invest in technology development, or reduce debt without relying on external equity financing. The company holds cash reserves of $31.55M against total debt of $12,137, resulting in a debt-to-equity ratio of 0.04, which characterizes the balance sheet as highly conservative and minimally leveraged. This strong liquidity position is further supported by a current ratio of 2.96, indicating that the company possesses nearly three times the current assets necessary to cover its short-term liabilities. However, the return on equity stands at -9.6% and the return on assets is -5.1%, metrics that reveal that management has not yet achieved positive capital efficiency and that the equity base is being eroded by current operational losses.
밸류에이션 평가
Forian Inc. does not have a trailing P/E ratio due to its lack of net income, but it trades with a forward P/E of 23.78, implying that the market prices the stock based on anticipated future earnings rather than current profitability. The price-to-book ratio is 2.23, suggesting that the market values the company at more than double its book value, potentially reflecting expectations of future growth or intangible asset value not fully captured on the balance sheet. Alternative valuation metrics such as the price-to-sales ratio of 2.21 and an EV/EBITDA of -9.93 provide context for investors, indicating that the valuation is primarily driven by revenue multiples given the negative earnings multiple. The stock's 52-week trading range spans from a low of $1.64 to a high of $2.71, meaning the current price sits within this historical band and reflects recent volatility around the upper end of the previous year's range. With a beta of 0.99, the stock exhibits price volatility that closely mirrors the broader market, indicating that it does not amplify or dampen market movements significantly compared to the overall index.
Growth & Income
Forian Inc. achieved a revenue growth rate of 37.0% year-over-year, while earnings growth is listed as N/A due to the absence of prior period net income comparisons. The disparity between strong revenue expansion and the lack of reported earnings growth implies that the company is prioritizing market share capture and product development over immediate profit generation in its early commercialization phase. As a non-dividend payer, Forian Inc. maintains a dividend yield of N/A and a payout ratio of 0.0%, indicating that the company reinvests all available cash flow and earnings into business expansion rather than distributing income to shareholders. This reinvestment strategy is consistent with the company's profile as a small-cap growth firm that relies on internal capital generation and its substantial cash reserves to fuel innovation in data management and analytics solutions within the life science and healthcare sectors.